Life ScienceCompany
ImmunoGen Ownership
Who owns ImmunoGen?
ImmunoGen is owned by AbbVie. It was acquired on November 30, 2023.
Was ImmunoGen formerly PE-backed?
Yes. ImmunoGen was formerly owned by 1 private investor.
ImmunoGen Business Overview
Where is ImmunoGen headquartered?
ImmunoGen is headquartered in Waltham, Massachusetts.
What is ImmunoGen’s revenue?
ImmunoGen disclosed revenue of 109M USD for 2022 and 70M USD for 2021.
How many employees does ImmunoGen have?
ImmunoGen has 277 employees.
What sector is ImmunoGen in?
ImmunoGen is a life science company.
When was ImmunoGen founded?
ImmunoGen was founded in 1980.
Life Science M&A Summary in 2023
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.
Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.